Pacific Biosciences Adds More Than $50 Million

Pacific Biosciences, a Menlo Park, Calif.-based DNA gene sequencing company, has raised $50 million in Series F funding from Gen-Probe Inc. (Nasdaq: GPRO). The company also raised an undisclosed amount of funding from existing shareholders. Pacific Biosciences previously raised around $253 million from Monsanto, the Wellcome Trust, Sutter Hill Ventures, Deerfield Management, Intel Capital, Morgan Stanley, Redmile Group, T. Rowe Price, Mohr Davidow Ventures, Kleiner Perkins Caufield and Byers, Alloy Ventures, Maverick Capital, AllianceBernstein, DAG Ventures, Teachers’ Private Capital and Blackstone Cleantech Venture Partners.

North AmericaUSBriefs